
04 Apr 2023 Wellbeing
£200 grants for people affected by leukaemia once again available
Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), whose lives have been impacted by the ongoing cost of living crisis.
Applications are open now for grants of up to £200 provided by the Leukaemia UK and Leukaemia Care ‘Cost of Living Fund’. Over £168,000 was given to families affected by leukaemia, MDS or an MPN in 2022. Together, Leukaemia UK and Leukaemia Care hope that the relaunch of this fund will provide much-needed support during one of the most difficult times of a person’s life.
Fiona Hazell, Chief Executive of Leukaemia UK, said:
“The relaunch of the Cost of Living with Leukaemia Fund will help to improve the lives of more people across the UK living with leukaemia. The emotional and physical challenges of leukaemia are profound, and the diagnosis often brings additional financial pressures during what is already one of the most difficult times of a person’s life. The Cost of Living with Leukaemia Fund will make a tangible difference to their lives, and we are very grateful to our supporters for making this relaunch possible.”
Please visit the Leukaemia Care website to find out more.
Related posts
26 October 2021
Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke
Leukaemia UK is delighted to have been announced as one of five charities for whom the proceeds of a new star-studded dance event, Shall We Dance?, will go towards when it takes place next year.
1 August 2022
Pedalling pair’s crazy peaks challenge to stop leukaemia cutting short the lives of beloved mums
Leukaemia UK supporter, Alistair, who lost is mum to leukaemia less than a year ago, is setting out on an extreme fundraising challenge. Alistair, who is from Lincoln, and his…
22 May 2023
Can the unique differences between stem cells tell us how well CML treatment will work?
What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…
5 March 2025
Leukaemia UK chosen to be featured charity partner of Scrap Car Comparison
Leukaemia UK will be the featured charity partner of Scrap Car Comparison’s ‘Donate a Car’ scheme this March. The scheme will help raise money to stop leukaemia devastating lives by…